Literature DB >> 34866601

Structure of mitogen-activated protein kinase kinase 1 in the DFG-out conformation.

Setsu Nakae1, Maho Kitamura1, Daisuke Fujiwara1, Masaaki Sawa2, Tsuyoshi Shirai3, Ikuo Fujii1, Toshiji Tada1.   

Abstract

Eukaryotic protein kinases contain an Asp-Phe-Gly (DFG) motif, the conformation of which is involved in controlling the catalytic activity, at the N-terminus of the activation segment. The motif can be switched between active-state (DFG-in) and inactive-state (DFG-out) conformations: however, the mechanism of conformational change is poorly understood, partly because there are few reports of the DFG-out conformation. Here, a novel crystal structure of nonphosphorylated human mitogen-activated protein kinase kinase 1 (MEK1; amino acids 38-381) complexed with ATP-γS is reported in which MEK1 adopts the DFG-out conformation. The crystal structure revealed that the structural elements (the αC helix and HRD motif) surrounding the active site are involved in the formation/stabilization of the DFG-out conformation. The ATP-γS molecule was bound to the canonical ATP-binding site in a different binding mode that has never been found in previously determined crystal structures of MEK1. This novel ATP-γS binding mode provides a starting point for the design of high-affinity inhibitors of nonphosphorylated inactive MEK1 that adopts the DFG-out conformation.

Entities:  

Keywords:  DFG motif; MAP kinases; MEK1; X-ray crystallography; human mitogen-activated protein kinase kinase 1

Mesh:

Substances:

Year:  2021        PMID: 34866601      PMCID: PMC8647213          DOI: 10.1107/S2053230X21011687

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  26 in total

Review 1.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 2.  MEK1/2 dual-specificity protein kinases: structure and regulation.

Authors:  Robert Roskoski
Journal:  Biochem Biophys Res Commun       Date:  2011-12-08       Impact factor: 3.575

Review 3.  Protein kinases: evolution of dynamic regulatory proteins.

Authors:  Susan S Taylor; Alexandr P Kornev
Journal:  Trends Biochem Sci       Date:  2010-10-23       Impact factor: 13.807

4.  Molecular replacement with MOLREP.

Authors:  Alexei Vagin; Alexei Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

Review 5.  The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling.

Authors:  Arvin C Dar; Kevan M Shokat
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

Review 6.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

7.  Structural basis for the autoinhibition of c-Abl tyrosine kinase.

Authors:  Bhushan Nagar; Oliver Hantschel; Matthew A Young; Klaus Scheffzek; Darren Veach; William Bornmann; Bayard Clarkson; Giulio Superti-Furga; John Kuriyan
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

Review 8.  The structural basis for control of eukaryotic protein kinases.

Authors:  Jane A Endicott; Martin E M Noble; Louise N Johnson
Journal:  Annu Rev Biochem       Date:  2012-04-05       Impact factor: 23.643

9.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  1 in total

1.  1,5-Benzothiazepine Derivatives: Green Synthesis, In Silico and In Vitro Evaluation as Anticancer Agents.

Authors:  Michelyne Haroun; Santosh S Chobe; Rajasekhar Reddy Alavala; Savita M Mathure; Risy Namratha Jamullamudi; Charushila K Nerkar; Vijay Kumar Gugulothu; Christophe Tratrat; Mohammed Monirul Islam; Katharigatta N Venugopala; Mohammed Habeebuddin; Mallikarjun Telsang; Nagaraja Sreeharsha; Md Khalid Anwer
Journal:  Molecules       Date:  2022-06-10       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.